FIELD: pharmacology.
SUBSTANCE: invention concerns the use of 5,6,8-trihydroxy-2,3-diglutathionyl-7-ethyl-1,4-naphthoquinone as an agent for the treatment of cerebral ischemia in acute cerebrovascular disorders. The invention results in a faster reduction of the edema zone in comparison with analogues.
EFFECT: expansion of the arsenal of funds intended for the treatment of cerebral ischemia in acute disorders of cerebral circulation, low toxicity, good solubility in physiological saline and storage time.
8 dwg, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
NEUROPROTECTIVE AGENT | 2021 |
|
RU2765956C1 |
METHOD FOR PREDICTION OF SEPSIS DEVELOPMENT IN PATIENTS WITH NONTRAUMATIC INTRACEREBRAL BLEEDING | 2016 |
|
RU2641174C2 |
METHOD FOR TREATING STROKE CASES | 2004 |
|
RU2283121C2 |
MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
METHOD OF DIAGNOSING CHANGES IN PERIFOCAL REGION DURING SMALL SUPRATENTORIAL INTRACEREBRAL BLEEDING | 2008 |
|
RU2363380C1 |
METHOD AND PREPARATION FOR TREATING THE CASES OF HEMORRHAGIC STROKE | 2004 |
|
RU2266737C1 |
EMBALOGENIC MATRIX DECOMPOSITION METHOD IN EXPERIMENT | 2020 |
|
RU2739669C1 |
MEDICINAL COMPOSITION | 2001 |
|
RU2213562C2 |
METHOD FOR TREATING FOCAL INJURIES OF BRAIN | 2001 |
|
RU2188674C1 |
METHOD FOR BRAIN NEUROPROTECTION IN SIMULATING PHOTOINDUCED ISCHEMIC STROKE | 2023 |
|
RU2816057C1 |
Authors
Dates
2017-07-18—Published
2016-10-10—Filed